Our business

Return of capital FAQs

IMPORTANT - disclaimer

Please read this notice carefully – it applies to all persons who view this webpage and, depending on who you are and where you live, it may affect your rights. Please note that this notice and the information contained in it may be altered or updated from time to time, and should be read in full each time you visit the site. In addition, the contents of this webpage may be amended at any time in whole or in part at the sole discretion of Aviva Plc ("Aviva")

Access to the materials contained in this section of the website (the "Microsite") may be restricted under securities laws in certain jurisdictions. This notice requires you to confirm certain matters (including that you are not resident or located in such a jurisdiction) before you may obtain access to the information on the website. If you are unable, or have any doubt whether you are able to provide the necessary confirmation you should press 'decline' and you will not be able to view information about the B Share Scheme (as defined below) and Share Consolidation (as defined below).

These materials are not directed at or to be accessed by persons resident or located in any jurisdiction where to do so would constitute a violation of the relevant laws or regulations of that jurisdiction or may result in a significant risk of civil, regulatory or criminal exposure if information concerning the acquisition is sent or made available to persons in that jurisdiction (a "Restricted Jurisdiction") and unless otherwise determined by Aviva and permitted by applicable law and regulation, it is not intended that these materials be accessible by persons resident or located in any restricted jurisdiction.

Electronic versions of the materials you are seeking to access are being made available on this microsite by Aviva in good faith, for information purposes only and subject to the terms and conditions set out below.

Basis of access

The information contained on this Microsite is in respect of the return of capital to the holders of the ordinary shares of 25 pence each in the capital of Aviva in issue as shown on the register of members of Aviva as at 6pm (UK time) on 13 May 2022 (or such other time and date as the board of directors of Aviva may determine) (the Existing Ordinary Shares and each an Existing Ordinary Share) of £3.75 billion through the issue of a new class of B shares which Aviva intends to redeem for cash in order to return an expected amount of 101.69 pence per each Existing Ordinary Share referred to as the “B Share Scheme” and the 76 for 100 consolidation of Aviva’s ordinary share capital which will accompany the B Share Scheme (“Share Consolidation”). Holders of Aviva’s American depositary shares (“ADSs”) will be entitled to participate in the return under the B Share Scheme and Share Consolidation. The shareholder circular, in respect of the B Share Scheme and Share consolidation is scheduled to be published on 5 April 2022, with the general meeting of the shareholders to approve the return to be held on 9 May 2022.

Responsibility

The information contained on this Microsite speaks only at the date of the relevant document or announcement reproduced on this Microsite, and Aviva does not accept responsibility or duty to update any such information, document or announcement. Aviva reserves the right to add to, remove or amend any information reproduced on this Microsite at any time.

In relation to any document, announcement or information contained on the Microsite, the only responsibility accepted by the directors of Aviva ("Responsible Persons") is for the correctness and fairness of its reproduction or presentation unless a responsibility statement in any relevant document expressly provides otherwise.

None of the Responsible Persons or Aviva have reviewed, and none of them is or shall be responsible for or accepts any liability in respect of any information contained on any other website that may be linked to this Microsite by a third party.

If you are in any doubt about the contents of this Microsite or the action you should take, you should seek your own financial advice from an independent financial adviser authorised under the Financial Services and Markets Act 2000 or, if you are located outside the United Kingdom, from an appropriately authorised independent financial adviser.

Overseas persons

Shareholders who are not resident in the United Kingdom or who are citizens, residents or nationals of other countries should consult their professional advisers to ascertain whether the issue, holding, redemption or disposal of the B Shares will be subject to any restrictions or require compliance with any formalities imposed by the laws or regulations of, or any body or authority located in, the jurisdiction in which they are resident or to which they are subject. In particular, it is the responsibility of any overseas Shareholder to satisfy itself as to full observance of the laws of each relevant jurisdiction in connection with the B Share Scheme and Share Consolidation, including the obtaining of any government, exchange control or other consents which may be required, or the compliance with other necessary formalities needing to be observed and the payment of any issue, transfer or other taxes or duties in such jurisdiction.

The information contained in the Microsite is not being, and must not be released or otherwise forwarded, published, distributed or sent, in whole or in part, directly or indirectly, in or into certain jurisdictions. Viewing the materials you seek to access may be unlawful if you are resident or located in certain jurisdictions where only certain categories of person may be allowed to view such materials. Persons into whose possession this document comes should inform themselves about and observe any such restrictions. Neither this document nor any other document issued or to be issued by or on behalf of Aviva in connection with the B Share Scheme or Share Consolidation constitutes an invitation, offer or other action on the part of Aviva in any jurisdiction in which such invitation, offer or other action is unlawful.

If you are not permitted to view materials on this Microsite please exit this Microsite. Should you be in any doubt about whether you are permitted to view materials on this Microsite, you should not access the Microsite and you should take legal advice. To the fullest extent permitted by applicable law, neither Aviva nor its advisers accepts responsibility for any violation by any person of these restrictions and disclaim any responsibility or liability for the violations of any such restrictions by any person.

Securities law considerations in the United States

The redeemable preference shares of 101.69 pence nominal value each (subject to adjustment in the discretion of Aviva’s board of directors) in the capital of Aviva (‘‘B Shares'') have not been or will not be registered under the US Securities Act or the state securities laws of the United States and they may not be distributed, offered or sold in the United States unless pursuant to a transaction that has been registered under the US Securities Act and the relevant state securities laws or pursuant to a transaction that is exempt from the registration requirements of the US Securities Act and the state securities laws.

Forward-looking statements

This Microsite should be read in conjunction with the documents distributed by Aviva through the Regulatory News Service of the London Stock Exchange.

This Microsite contains, and we may make other verbal or written 'forward-looking statements'. Statements containing the words 'believes', 'intends', 'expects', 'projects', 'plans', 'will', 'seeks', 'aims', 'may', 'could', 'outlook', 'likely', 'target', 'goal', 'guidance', 'trends', 'future', 'estimates', 'potential' and 'anticipates', and words of similar meaning, are forward-looking. These forward-looking statements include all matters that are not historical facts. By their nature, all forward-looking statements involve risk and uncertainty. Accordingly, there are or will be important factors that could cause actual results to differ materially from those indicated in this Microsite. Aviva believes factors that could cause actual results of the tax treatment applicable to Shareholders, Aviva's operations and financial position, and the development of the markets and the industry in which Aviva operates, to differ materially from those indicated in forward-looking statements in this Microsite include, but are not limited to: tax laws and regulations and their interpretation by government authorities, the impact of ongoing uncertain conditions in the global financial markets and the local and international political and economic situation generally (including those arising from the Russia-Ukraine conflict); market developments and government actions (including those arising from the evolving relationship between the UK and the European Union (EU)); the effect of credit spread volatility on the net unrealised value of the investment portfolio; the effect of losses due to defaults by counterparties, including potential sovereign debt defaults or restructurings, on the value of Aviva’s investments; changes in interest rates that may cause policyholders to surrender their contracts, reduce the value or yield of Aviva’s investment portfolio and impact Aviva’s asset and liability matching; the unpredictable consequences of reforms to reference rates, including the London Inter-Bank Offered Rate (LIBOR); the impact of changes in short or long-term inflation; the impact of changes in equity or property prices on Aviva’s investment portfolio; fluctuations in currency exchange rates; the effect of market fluctuations on the value of options and guarantees embedded in some of Aviva’s life insurance products and the value of the assets backing their reserves; the amount of allowances and impairments taken on Aviva’s investments; the effect of adverse capital and credit market conditions on Aviva’s ability to meet liquidity needs and Aviva’s access to capital; changes in, or restrictions on, Aviva’s ability to initiate capital management initiatives; changes in or inaccuracy of assumptions in pricing and reserving for insurance business (particularly with regard to mortality and morbidity trends, lapse rates and policy renewal rates), longevity and endowments; a cyclical downturn of the insurance industry; the impact of natural and man-made catastrophic events (including the impact of COVID-19) on Aviva’s business activities and results of operations; the transitional, litigation and physical risks associated with climate change; Aviva’s reliance on information and technology and third-party service providers for Aviva’s operations and systems; the impact of the Group's risk mitigation strategies proving less effective than anticipated, including the inability of reinsurers to meet obligations or unavailability of reinsurance coverage; poor investment performance of the Group's asset management business; the withdrawal by customers at short notice of assets under the Group's management; failure to manage risks in operating securities lending of Group and third-party client assets; increased competition in the UK and in other countries where we have significant operations; regulatory approval of changes to the Group's internal model for calculation of regulatory capital under the UK's version of Solvency II rules; the impact of actual experience differing from estimates used in valuing and amortising deferred acquisition costs and acquired value of in-force business; the impact of recognising an impairment of Aviva’s goodwill or intangibles with indefinite lives; changes in valuation methodologies, estimates and assumptions used in the valuation of investment securities; the effect of legal proceedings and regulatory investigations; the impact of operational risks, including inadequate or failed internal and external processes, systems and human error or from external events and malicious acts (including cyberattack and theft, loss or misuse of customer data); risks associated with arrangements with third parties, including joint ventures; Aviva’s reliance on third-party distribution channels to deliver its products; funding risks associated with Aviva’s participation in defined benefit staff pension schemes; the failure to attract or retain the necessary key personnel; the effect of systems errors or regulatory changes on the calculation of unit prices or deduction of charges for Aviva’s unit-linked products that may require retrospective compensation to Aviva’s customers; the effect of simplifying Aviva’s operating structure and activities; the effect of a decline in any of Aviva’s ratings by rating agencies on Aviva’s standing among customers, broker-dealers, agents, wholesalers and other distributors of Aviva’s products and services; changes to Aviva’s brand and reputation; changes in tax laws and interpretation of existing tax laws in jurisdictions where we conduct business; changes to International Financial Reporting Standards relevant to insurance companies and their interpretation (for example, IFRS 17); the inability to protect Aviva’s intellectual property; the effect of undisclosed liabilities, execution and separation issues and other risks associated with Aviva’s business disposals; and other uncertainties, such as diversion of management attention and other resources, relating to future acquisitions, combinations or disposals within relevant industries; the policies, decisions and actions of government or regulatory authorities in the UK, the EU, the US, Canada or elsewhere, including changes to and the implementation of key legislation and regulation. Please see Aviva’s most recent Annual Report for further details of risks, uncertainties and other factors relevant to the business and its securities. You should specifically consider the factors identified in this Microsite which could cause actual results to differ before making any decision in relation to the B Share Scheme and the Share Consolidation.

Subject to the requirements of the Financial Conduct Authority of the United Kingdom (or any successor body in respect thereof), the London Stock Exchange, the Listing Rules and the Disclosure Guidelines and Transparency Rules or applicable law, Aviva explicitly disclaims any obligation or undertaking publicly to revise or update the forward-looking statements in this Microsite or any other forward-looking statements we may make. Forward-looking statements in this Microsite are current only as of the date on which such statements are made.

This notice shall be governed by and interpreted in accordance with English law.

THE INFORMATION CONTAINED IN THIS MICROSITE MAY NOT BE DOWNLOADED, FORWARDED, TRANSMITTED OR SHARED WITH ANY OTHER PERSON EITHER IN WHOLE OR IN PART WHERE TO DO SO WOULD OR MAY CONSTITUTE A BREACH OF ANY APPLICABLE LOCAL LAWS OR REGULATIONS.

Confirmation of understanding and acceptance of disclaimer

By accessing the FAQs below, you:

  • confirm that you are permitted to proceed to this Microsite and certify that you are not (nor do you act on behalf of someone who is) resident or located in, or a national or citizen of, any jurisdiction that renders the accessing of this Microsite or any parts thereof illegal;
  • agree that you will not forward, transfer or distribute (by any means including by electronic transmission) any information or documents included in this Microsite either in whole or in part to any person in any jurisdiction where such distribution may be restricted by applicable law or regulation;
  • represent and warrant to Aviva that you intend to access this area of the website for information purposes only, that you have read and understood this notice and that you understand that it may affect your rights or responsibilities; and
  • have read and understood the notice set out above and agree to be bound by the terms of this notice and are permitted to proceed to this Microsite.

Restricted

The information in these FAQs should only be accessed if you accept the terms of this disclaimer.

Frequently Asked Questions (FAQs)

To help you understand what is involved in the B Share Scheme with respect to Ordinary Shares and ADSs representing Ordinary Shares we have prepared some questions and answers. These FAQs should be read in conjunction with the circular to Shareholders (the “Circular”) and are subject to the terms of the disclaimerYou should read the whole of the Circular for further information and before making any investment decisions, and should not rely solely on the summary information on this page. Part II of the Circular sets out the detailed terms and conditions of the B Share Scheme with respect to Ordinary Shares and ADSs representing Ordinary Shares. All capitalised terms in these FAQs have the meaning ascribed to them in Part VI ‘‘Definitions'' of the Circular.

In the event of any inconsistency between the contents of these FAQs and the terms and conditions set out in Part II of the Circular, the terms and conditions set out in the Circular shall prevail.

Please enable your browser JavaScript to view the video

If you're an Aviva ordinary shareholder, you may have received a notification about two upcoming actions. First, the proposed return of £3.75bn of cash to ordinary shareholders in May, through a mechanism known as a B share scheme, with shareholders receiving just over £1 in cash for every Aviva share owned.

Secondly, the reduction of the total number of Aviva ordinary shares in issue through a share consolidation of 76 new shares for 100 existing shares.

The Capital Return section of Aviva.com has a short explanatory film as well as more detailed frequently asked questions.

In this film, we've asked our group chief financial officer, Jason Windsor, to give a little more colour on the main aspects of the transactions by answering some of the key questions.

Why are we returning £3.75bn to shareholders?

Over the last year, we've successfully focused Aviva on the attractive markets of the UK, Ireland and Canada.

We sold eight businesses for around 7.5 billion pounds. We are using this cash to reduce debt, invest in the business and pay out some to our shareholders.

We're returning capital to shareholders through a 1 billion pound share buyback programme that finished in March. And we are now returning 3.75 billion pounds to our ordinary shareholders through a B share scheme.

What is a B share scheme?

A B share scheme is simply a mechanism to return capital to shareholders.

In our B share scheme, every shareholder will receive one new B share, for each ordinary Aviva share that they hold.

The B shares are not traded. Shortly after they are issued, we will automatically pay a fixed amount of just over £1 per share in cash to redeem all of the B shares issued.

Why did you choose a B share scheme rather than a special dividend?

We decided on a B share scheme because the Board believes it is the most favourable method for returning capital to both retail and institutional shareholders. We can return the cash quickly and all shareholders can participate.

The vast majority of our UK shareholders will see a B share payment taxed as a capital gain, while a special dividend would be classified as income.

Whilst we are on the subject of dividends, the B share payment is on top of the normal dividend. So shareholders who receive two sets of payments in May, the 2021 final dividend of 14.7 pence per share, and the B share payment.

There is further information on the B share scheme in the circular and the FAQs, both of which can be found on the Aviva website.

Why are we undertaking a share consolidation?

Share consolidations are often undertaken by companies when returning a large amount of capital to shareholders. The aim of the share consolidation is to maintain comparability of the share price of Aviva before and after the B share scheme.

In fact, without a share consolidation, we would expect Aviva shares to fall by around 25%.

So through the consolidation, each shareholder will receive 76 new shares for each 100 existing shares, and the total number of shares issued by Aviva reduces by the same proportion. This means that shareholders will own the same percentage of Aviva as before the consolidation, and the share price is expected to be broadly unchanged by the combined effect of B share and the consolidation.

Again, there is further information on the share consolidation in the circular and the FAQs, on the Aviva website.

Are shareholders better or worse off as a result of these changes?

The board and I believe this is the right course of action for Aviva and its shareholders. And there is no reason to hold excess capital in the business.

As just mentioned, each shareholder will continue to hold the same proportion of Aviva as before these changes.

What does change for shareholders is that around a quarter of the value of their current Aviva shares is returned in cash.

Let’s use an example share price of 423.3 pence and 100 shares. So the total value is 423 pounds before the changes. From the B share and consolidation, the same shareholder with 100 shares would receive approximately 101 pounds in cash, 76 new shares, worth approximately 322 pounds. The total value would therefore be approximately 423 pounds.

I would encourage everyone to visit the calculator on Aviva.com, where you can enter your current shareholding and receive an estimate of the value of the cash proceeds and the number of new shares that you will receive.

Will shareholders receive reduced dividends in future as a result of owning fewer shares?

With the reduction in the number of shares following the consolidation and the expected growth in the company's cash flows, we expect dividends per share in 2022 to be approximately 40% higher than in 2021.

Of course, dividends are not guaranteed, and the actual payments will depend on the performance of the business.

Can I reinvest the cash received through the B share payment and buy more Aviva shares?

Of course you can reinvest. How to do it depends on how you hold your shares.

If you want to reinvest, we recommend you contact your broker, bank or share dealing platform to see what options they can offer you.

If you are considering investing the money in shares in Aviva, and you are unsure as to what action to take, please seek independent financial advice.

What are the tax implications?

For UK taxpayers, the B share scheme may give rise to a capital gain for the purposes of tax.

Any gain would be taxable at the applicable capital gains tax rate, and shareholders should remember their annual tax allowance for capital gains. However, each shareholders' tax situation does depend on their particular circumstances.

If you have any questions, read the circular and seek independent advice.

What are the next steps?

On Monday, May 9th, we will hold a special general meeting where we will ask ordinary shareholders to vote on the proposals.

Shareholders do not need to attend the meeting in-person to vote. This can be done online or by post by completing and returning the voting form sent to all shareholders and these need to be received by us, by Thursday, 5th May.

Any ADR holders should refer to the timetable in the circular.

If the B share scheme and share consolidation are approved, the record date for the B shares and share consolidation is Friday, 13th May, with the B share redemption payment made to shareholders by Tuesday, 31st May.

What do shareholders need to do next?

As a shareholder, you don't need to do anything. Just make sure that your address, bank details are correct to avoid any delays in receiving your payment, and remember to vote at the general meeting.

 

The B Share Scheme is the way in which Aviva proposes to return £3.75 billion to Shareholders. This will involve issuing B Shares to Shareholders, at a ratio of one B Share for each Existing Ordinary Share held, and then redeeming the B Shares for a fixed amount per B Share. Holders of the ADSs will also be entitled to participate in the return under the B Share Scheme.

To maintain comparability (subject to normal market fluctuations) between the market price for Aviva Ordinary Shares and ADSs before and after the implementation of the B Share Scheme, the B Share Scheme will be accompanied by a Share Consolidation (and an equivalent consolidation of the ADSs). Under the proposed Share Consolidation, the Existing Ordinary Shares will be consolidated and redesignated so that Shareholders will receive 76 New Ordinary Shares for each 100 Existing Ordinary Shares held at the Record Time. The ratio applied in respect of the Share Consolidation is subject to review and may change, to ensure that the correct ratio is applied in order to maintain comparability (subject to normal market fluctuations) as intended.

 

Shareholders will receive one B Share for each Existing Ordinary Share held at the Record Time, which is expected to be at 6pm on Friday 13 May 2022, with B Shares redeemed for cash (expected to be 101.69 pence per Existing Ordinary Share). The number of Existing Ordinary Shares held by each Shareholder at the Record Time will determine how many B Shares that Shareholder is issued.

The estimated proceeds of approximately 100 pence per Existing Ordinary Share at the Record Time published in the Company’s Results Announcement and the announcement on proposed return to Shareholders on Wednesday 2 March 2022 were for illustrative and indicative purposes only and, subject to unforeseen events, the expected proceeds per Existing Ordinary Share will be as set out above (and not on the basis of that earlier illustrative amount).

If, at the Record Time, the number of Existing Ordinary Shares in issue multiplied by the expected redemption payment per Existing Ordinary Share stated above would result in a return in excess of £3.75 billion, then the redemption amount payable by reference to each Existing Ordinary Share may be subject to a downward adjustment at the discretion of the Board.

 

The expected return of 101.69 pence per Existing Ordinary Share has been calculated by dividing £3.75 billion by the number of Existing Ordinary Shares the Company expects to have in issue at the Record Time. 

This expected share count has been calculated by adjusting the number of Existing Ordinary Shares in issue as at Monday 4 April 2022 (being the last practicable date prior to the publication of the Circular) for the number of Ordinary Shares which are pending cancellation as at such date under the previously announced share buyback programme. If the number of Existing Ordinary Shares in issue at the Record Time is greater than expected, such that returning 101.69 pence per Existing Ordinary Share would result in a return of capital which exceeds £3.75 billion, then the return per Existing Ordinary Share may, at the discretion of the Board, be reduced by such amount as is required to prevent the aggregate return of capital from exceeding £3.75 billion. Any change to such return per Existing Ordinary Share will be announced to the market by RNS.

 
The expected key dates are as follows:
  • Tuesday 29 March 2022 - Record date for ADS Holder entitlement to vote at General Meeting
  • Tuesday 5 April 2022 - Publication of Circular and Notice of General Meeting
  • Monday 11 April 2022 - Posting of Circular and Notice of General Meeting
  • Thursday 5 May 2022 - Record date for Shareholder entitlement to vote at General Meeting
  • Monday 9 May 2022 - General Meeting
  • 6pm on Friday 13 May 2022 - Record time for entitlement to B Shares and Share Consolidation in respect of Existing Ordinary Shares 
  • By Tuesday 31 May 2022 - Redemption payment settlement date for B shares 
  • Promptly after Monday 6 June 2022 - Redemption payment settlement date for ADSs 

Please note that the full timetable is set out in the Circular and dates are subject to amendment as set out in the Circular.

 

Over the course of the past 18 months Aviva has agreed and completed the disposal of eight non-core businesses for total proceeds of £7.5 billion. 

A share buyback programme, which commenced in August 2021 and completed on Thursday 31 March 2022, returned £1 billion to Shareholders. After taking into account the disposal proceeds received, Aviva’s strong financial position and capital framework, together with the desire to retain amounts for the further reduction in financial leverage and for investment in the business, the Board is proposing a further return of £3.75 billion to Shareholders by way of a B Share Scheme. 

The Board has concluded that the B Share Scheme would be the most favourable method for returning capital to Shareholders on the basis of the position of both retail and institutional Shareholders, the benefits of completing the capital return within a reasonable timescale and the proportionate participation of all Shareholders.

 

The B Share Scheme and Share Consolidation relate to the ordinary share capital of Aviva. All Ordinary Shareholders on Aviva’s shareholder register at the Record Time (being 6pm on Friday 13 May 2022) will, once Resolutions 1 to 3 have been approved at the General Meeting, be eligible to participate in the B Share Scheme and their Existing Ordinary Shares will be consolidated.

 

The purpose of the Share Consolidation is to try to ensure that (subject to fractional roundings) the market price of each New Ordinary Share and New ADS immediately following the implementation of the B Share Scheme is broadly the same (subject to normal market fluctuations) as the market price of each Existing Ordinary Share and ADS immediately beforehand. The New Ordinary Shares will be equivalent in all other respects to the Existing Ordinary Shares, including their dividend, voting and other rights as set out in Aviva’s Articles of Association.

In addition, you will continue to own the same proportion of Aviva (subject to fractional entitlements) as you did immediately prior to the implementation of the B Share Scheme. Under the proposed Share Consolidation, the Existing Ordinary Shares will be consolidated and redesignated so that Shareholders will receive 76 New Ordinary Shares for 100 Existing Ordinary Shares held at the Record Time. The ratio applied in respect of the Share Consolidation is subject to review and may change, to ensure that the correct ratio is applied in order to maintain comparability (subject to normal market fluctuations) as intended. Expressed as a percentage, the reduction in the number of Ordinary Shares as a result of the Share Consolidation is broadly equivalent to the percentage of Aviva’s market capitalisation which is proposed to be returned to Shareholders under the B Share Scheme. Therefore, the value of your holding of New Ordinary Shares plus the amount to be returned per Existing Ordinary Share held by you at the Record Time pursuant to the B Share Scheme should, subject to market fluctuations, approximately equal the value of your holding of Existing Ordinary Shares before the B Share Scheme.

Fractional entitlements arise when applying the consolidation ratio to a Shareholder’s holding of Existing Ordinary Shares would result in the Shareholder being entitled to a fraction of a New Ordinary Share. Such fractional entitlements will be aggregated and sold in the market on behalf of such Shareholders. Net proceeds of the sale (after deduction of all expenses and commissions incurred) are expected to be distributed pro rata to entitled Ordinary Shareholders by Tuesday 31 May 2022. The value of any one Shareholder's fractional entitlement will not exceed the value of one New Ordinary Share.

At or around the same time as the Share Consolidation, the Depositary will consolidate the ADSs in the same manner as the Existing Ordinary Shares to reflect the Share Consolidation, with fractional entitlements to New ADSs being sold and net cash proceeds (net of applicable fees, taxes, and expenses) being distributed to applicable ADS Holders.

 

The consolidation ratio included in the Company’s Results Announcement and the announcement on the proposed return of capital to Shareholders on Wednesday 2 March 2022 was for illustrative purposes only. The Share Consolidation will proceed on the basis of the ratio set out in the Circular (and not on the basis of that earlier illustrative ratio).

The ratio for the Share Consolidation that will apply to your shares has been set by reference to (i) the closing mid-market price of 438 pence per Existing Ordinary Share in issue on Monday 4 April 2022 (being the last practicable date prior to the publication of the Circular), as adjusted for the 2021 final dividend of 14.70 pence per Existing Ordinary Share (for which the record date is Friday 8 April 2022) and (ii) the number of Existing Ordinary Shares in issue on Monday 4 April 2022 (being the last practicable date prior to the publication of the Circular), adjusted for shares which are pending cancellation as at such date under the Company’s previously announced share buyback programme. The ratio applied in respect of the Share Consolidation is subject to review and may change, to ensure that the correct ratio is applied in order to maintain comparability (subject to normal market fluctuations) as intended.

 

For 1,000 Existing Ordinary Shares held by you, you will receive 1,000 B Shares which will be redeemed for cash for £1,016.901. Your shareholding will be consolidated on a 76 for 100 basis, meaning you will have 760 New Ordinary Shares in Aviva after the Share Consolidation.

The aggregate value of your cash redemption from the B Shares and your holding of 760 New Ordinary Shares in Aviva will, subject to normal market fluctuations, approximately equal the value of the 1,000 Existing Ordinary Shares that you previously held.

1 If, at the Record Time, the number of Existing Ordinary Shares in issue multiplied by the expected payment per Existing Ordinary Share would result in a return in excess of £3.75 billion, then the return per Existing Ordinary Share may be subject to a downward adjustment at the discretion of the Board.

 

Under the B Share Scheme, we expect that you will receive 101.692 pence for each Existing Ordinary Share you hold at the Record Time. Your Existing Ordinary Shares will then be consolidated into New Ordinary Shares in the ratio of 76 New Ordinary Shares for every 100 Existing Ordinary Shares you hold at the Record Time. The aggregate value of your cash proceeds under the B Share Scheme and your holding of New Ordinary Shares you hold following the Share Consolidation will, subject to normal market fluctuations, approximately equal the value of the Existing Ordinary Shares that you previously held. You will own the same proportion of Aviva shares as you did immediately prior to the implementation of the B Share Scheme and Share Consolidation subject only to fractional roundings.

The ratio for the Share Consolidation that will apply to your shares has been set by reference to (i) the closing mid-market price of 438 pence per Existing Ordinary Share in issue on Monday 4 April 2022 (being the last practicable date prior to the publication of the Circular), as adjusted for the 2021 final dividend of 14.70 pence per Existing Ordinary Share (for which the record date is Friday 8 April 2022) and (ii) the number of Existing Ordinary Shares in issue on Monday 4 April 2022 (being the last practicable date prior to the publication of the Circular), adjusted for shares which are pending cancellation as at such date under the Company’s previously announced share buyback programme. The ratio applied in respect of the Share Consolidation is subject to review and may change, to ensure that the correct ratio is applied in order to maintain comparability (subject to normal market fluctuations) as intended.

To give you an idea of how the B Share Scheme would affect your shareholding we have set out some examples below:

Number of Existing Ordinary Shares held at the B Share Scheme Record Time Number of B Shares you will receive Number of New Ordinary Shares you will receive
10 10 7
100 100 76
250 250 190

 

Fractional entitlements arise when applying the consolidation ratio to a Shareholder’s holding of Existing Ordinary Shares would result in the Shareholder being entitled to a fraction of a New Ordinary Share. Fractional entitlements arising from the Share Consolidation will be aggregated and sold in the market on behalf of such Shareholders. Net proceeds of the sale (after deduction of all expenses and commissions incurred) are expected to be distributed pro rata to entitled Ordinary Shareholders by Tuesday 31 May 2022. The value of any one Shareholder's fractional entitlement will not exceed the value of one New Ordinary Share.

ADSs will be consolidated in the same manner as the Existing Ordinary Shares, with fractional entitlements being sold and net cash proceeds (net of applicable fees, taxes, and expenses) being distributed to applicable ADS Holders.

2 If, at the Record Time, the number of Existing Ordinary Shares in issue multiplied by the expected payment per Existing Ordinary Share would result in a return in excess of £3.75 billion, then the return per Existing Ordinary Share may be subject to a downward adjustment at the discretion of the Board.

 

No, the B Share Scheme and Share Consolidation will not be a sale of any shares. The B Shares will be issued to you and then immediately redeemed and cancelled, for which you will receive a fixed return per share. The B Share Scheme issues shares to Shareholders pro rata to their Existing Ordinary Share holdings. Therefore, all Shareholders participate proportionally in the B Share Scheme and have an equivalent capital return.

The effect of the Share Consolidation is that the Existing Ordinary Shares will be replaced by New Ordinary Shares so as to reduce the number of Ordinary Shares in issue to reflect the amount of cash to be returned to Shareholders under the B Share Scheme. The Share Consolidation does not involve the sale of any shares to Aviva.

 

The B Share Scheme and Share Consolidation require the approval of Shareholders. This approval is being sought at the General Meeting on Monday 9 May 2022 at 3:30pm, immediately after the 2022 AGM (or 15 minutes after the 2022 AGM is concluded or adjourned, whichever is later).

The Resolutions to be considered at the General Meeting are explained in paragraph 13 of Part II of the Circular. Resolutions 1, 2, 5, 6, 8 and 9 will require a majority of 75 per cent. or more of the shares voted to be in favour in order to be passed. Resolutions 3, 4 and 7 will require a simple majority or more of the shares voted to be in favour in order to be passed. Resolutions 1, 2 and 3 on the adoption of new articles of association and the implementation of the B Share Scheme and Share Consolidation are inter-conditional, meaning that the Share Consolidation will not go ahead if the B Share Scheme is not approved and vice versa. The other Resolutions are subject to the passing of Resolutions 1, 2 and 3.

Whether or not you intend to be present at the General Meeting, you are requested to complete and return the accompanying Form of Proxy in accordance with the instructions printed thereon or to register the appointment of a proxy electronically or, if you hold Existing Ordinary Shares in CREST, to complete and transmit a CREST Proxy Instruction. Completed Forms of Proxy should be returned to Aviva’s Registrar, Computershare Investor Services PLC, at The Pavilions, Bridgwater Road, Bristol, BS99 6ZZ and the transmittal of an electronic proxy registration or CREST Proxy Instruction should be made, as soon as possible and, in any event, so as to be received not later than 3:30pm on Thursday 5 May 2022. The completion and return of a Form of Proxy or the transmittal of an electronic proxy registration or CREST Proxy Instruction will not prevent you from attending the General Meeting and voting and speaking in person if you so wish and are so entitled.

If you are an ADS Holder, please refer to the notes to the Notice of General Meeting in the Circular, which give further details relevant to you in respect of the General Meeting.

 

Once the Ordinary Shares are consolidated pursuant to the Share Consolidation on a 76 for 100 basis (or such other ratio as applied in respect of the Share Consolidation to ensure that the correct ratio is applied in order to maintain comparability, subject to normal market fluctuations, as intended), the total number of Ordinary Shares in issue will be reduced. The General Meeting Resolutions in respect of the authorities for share allotment, pre-emption disapplication and share buybacks are to refresh and update the equivalent AGM resolutions to take account of the effect of the Share Consolidation and are set by reference to latest available share count prior to publication of the Notice of Meeting for the General Meeting (adjusted for shares which are pending cancellation as at such date under the Company’s previously announced share buyback programme).

 

The Board considers the return of capital by way of the B Share Scheme and the accompanying Share Consolidation to be in the best interests of Aviva and the Shareholders as a whole. Accordingly, the Board unanimously recommends that Shareholders vote in favour of each of the Resolutions, as the Directors intend to do in respect of their own individual beneficial holdings.

 

Although Shareholders are encouraged to vote on the Resolutions which will be considered at the General Meeting, Shareholders are not under an obligation to do so.

In the event that Resolutions 1 to 3 are passed at the General Meeting and the conditions to the implementation of the B Share Scheme and Share Consolidation are satisfied, you will receive your portion of the proceeds of the B Share Scheme and your Existing Ordinary Shares will be replaced by New Ordinary Shares, regardless of whether or not you voted on the Resolutions.

In the event that one or more of Resolutions 1, 2 and 3 are not approved, due to the inter-conditionality between the Resolutions, the B Share Scheme and Share Consolidation would not be implemented. The other Resolutions are subject to the passing of Resolutions 1, 2 and 3.

 

Shareholders

Whether or not you intend to be present at the General Meeting, we would encourage Shareholders to vote on the Resolutions being proposed at the General Meeting.

If the Resolutions are approved, Aviva will have the authority required to implement the return of capital to Shareholders by means of the B Share Scheme and the Share Consolidation, which will both then be binding on all Shareholders (and ADS Holders) regardless of whether and how they voted. If you currently hold Existing Ordinary Shares in certificated form, you will be issued with a new share certificate in respect of your New Ordinary Shares following the Share Consolidation. With effect from Admission, share certificates in respect of Existing Ordinary Shares will cease to be valid. Share certificates in respect of New Ordinary Shares will only be issued following the Share Consolidation. It is therefore important that, if you hold certificate(s) in respect of your Existing Ordinary Shares, you retain them for the time being until share certificate(s) in respect of New Ordinary Shares are despatched, which is expected to be by Friday 27 May 2022. On receipt of share certificate(s) in respect of New Ordinary Shares, certificate(s) in respect of Existing Ordinary Shares can be destroyed. Please see paragraph 11 of Part II of the Circular for further information on the despatch of documents.

If you currently hold Existing Ordinary Shares in uncertificated form, it is currently expected that the Existing Ordinary Shares under ISIN GB0002162385 will be disabled by 6pm on the day before Admission (which is currently expected to be Friday 13 May 2022) and on or soon after 8am on Admission (which is currently expected to be Monday 16 May 2022) your CREST account will be credited with New Ordinary Shares under ISIN GB00BPQY8M80.

ADS Holders

If you are a registered holder of ADSs in certificated form, you will receive a template of the ADS Consolidation Letter of Transmittal from the Depositary and as soon as practicable after the ADS Effective Date (being Monday 6 June 2022) you must return the completed ADS Consolidation Letter of Transmittal to the Depositary accompanied by the ADSs held by you in order to be credited with New ADSs and cash in lieu of any fraction of a New ADS. Once a completed ADS Consolidation Letter of Transmittal has been returned with your ADSs, you will automatically become a participant in the Direct Registration System maintained by the Depositary. You will not receive an ADS evidencing New ADSs, but will be sent a transaction advice reflecting your holding of uncertificated New ADSs and further information about the Direct Registration System by the Depositary. Please note that failure to return a completed ADS Consolidation Letter of Transmittal and your ADSs will prevent the Depositary from sending you a transaction advice indicating your ownership of New ADSs and the cash proceeds in respect of the sale of your fractional entitlements and you will not be able to trade your ADSs. In time, your entitlements will lapse according to the applicable abandoned property laws in your jurisdiction.

If you already hold your ADSs in uncertificated form or in book-entry form through an Agent Institution, no further action needs to be taken by you. Your ADSs will automatically be exchanged for New ADSs and an appropriate notice will be provided to you by the Depositary or your Agent Institution.

 

The 2021 final dividend will not be impacted by the B Share Scheme or the Share Consolidation. The proposed final dividend for 2021, which is to be put to Shareholders at the 2022 AGM, is 14.70 pence per Existing Ordinary Share, payable on or around Thursday 19 May 2022 to Shareholders named on Aviva’s register of members as at the close of business on Friday 8 April 2022.

The effect of the Share Consolidation will be that the Existing Ordinary Shares will be replaced by the New Ordinary Shares so as to reflect the amount of cash to be returned to Shareholders pursuant to the B Share Scheme. The 2021 final dividend will not be impacted by the B Share Scheme or the Share Consolidation.

Going forward, the Company intends to pay dividends for financial years 2022 and 2023 in line with the underlying performance and cash generation of its businesses as announced in the Results Announcement, and these will be based on the share capital of the Company following the Share Consolidation.

 

The proposed 2021 final dividend of 14.70 pence per share is based on the number of Existing Ordinary Shares held at Friday 8 April 2022, which is prior to the Share Consolidation.

 

As every Shareholder’s shareholding is being consolidated at the same ratio, you will continue to hold the same percentage of Ordinary Shares as you did before, subject to fractional entitlements. Therefore you will continue to receive the same proportion of the total dividend amount that is declared each year.

Going forward, the Company intends to pay dividends for financial years 2022 and 2023 in line with the underlying performance and cash generation of its businesses as announced in the Results Announcement, and these will be based on the share capital of the Company following the Share Consolidation.

 

Ordinary Shareholders and ADS Holders may utilise the proceeds from the B Share Scheme however they wish to do so. Before making any decision with respect to the proceeds, please note that you may also need to pay taxation in respect of such proceeds.

If you are considering reinvesting the money in shares in Aviva, and you are unsure as to what action to take, please seek financial advice from your stockbroker, bank manager, fund manager, solicitor, accountant or other appropriate independent financial adviser duly authorised under the Financial Services and Markets Act 2000 (FSMA) if you are resident in the United Kingdom or, if not, from another appropriately authorised independent financial adviser. For your information only, details regarding Computershare’s securities dealing service are available at: www.computershare.com/AvivaDealing.

Please note that the B Share Scheme is separate to, and excluded from, the dividend re-investment plan and the B Share Scheme does not provide an option for Shareholders to automatically reinvest the proceeds from the B Share Scheme in shares in the Company. 

 

If you sell or have sold or otherwise transferred all of your Existing Ordinary Shares at any time prior to the Record Time, or ADSs prior to the ADS Effective Date (being Monday 6 June 2022), please forward the Circular and the accompanying documentation at once to the purchaser or transferee or to the bank, stockbroker or other agent through whom the sale or transfer was effected (or, in the case of the ADSs, the Depositary), for delivery to the purchaser or transferee. If you sell or have sold or otherwise transferred only part of your holding of Existing Ordinary Shares or ADSs, please consult the bank, stockbroker or other agent through whom the sale or transfer was effected (or, in the case of ADSs, the Depositary). However, such documents should not be forwarded to or sent in or into any jurisdiction in which to do so would constitute a breach of the relevant laws of such jurisdiction.

 

The B Shares will not be transferable, save in the very limited circumstances set out in the new Articles of Association (please refer to paragraph (G) of Part III of the Circular for further details), they will not be admitted to the Official List or to trading on the London Stock Exchange’s main market for listed securities or listed on the NYSE or any other recognised investment exchange as they are expected to be redeemed shortly after they are issued. No share certificates will be issued to the Shareholders in respect of the B Shares.

 

New Ordinary Shares will be admitted to the premium segment of the Official List and will be traded on the London Stock Exchange’s main market for listed securities and will be equivalent in all material respects (including as to the right to transfer) to Existing Ordinary Shares. It is expected that the New Ordinary Shares will be available for trading from 8am on Monday 16 May 2022.

It is expected that dealings in ADSs will continue to trade over the counter until 4pm (EST) on Friday 3 June 2022 and that dealings in the New ADSs will commence at 9:30am (EST) on Monday 6 June 2022.

 

Shareholders who are not resident in the UK or US, or who are citizens, residents or nationals of a country other than the UK or US, should read the additional information set out in paragraph 8 of Part II of the Circular.

In addition, Shareholders who are subject to tax in a jurisdiction other than the UK or the US, or who are in any doubt as to their tax position, should consult their own independent professional advisers.

 

Each Shareholder’s tax position will depend on their circumstances and where they are resident for tax purposes. The B Share Scheme is intended to provide capital treatment for most UK tax-resident Shareholders.

A general guide to certain limited aspects of the UK tax treatment of the B Share Scheme under current UK law and HMRC’s published practice and a summary of certain US federal income tax consequences for US holders under current US tax law is set out in Part IV of the Circular. Each Shareholder is urged to consult its own independent professional adviser regarding the tax consequences to it of the B Share Scheme, taking into account its particular circumstances.

Shareholders who are subject to tax in a jurisdiction other than the UK or the US, or who are in any doubt as to the potential tax consequences of the B Share Scheme or Share Consolidation, are urged to consult their own independent professional tax advisers.

 

Broadly speaking, for UK resident individual Shareholders who hold their shares as investments and did not acquire them from their employment, the receipt of cash under the B Share Scheme may give rise to a capital gain for the purposes of capital gains tax. In calculating the amount of any gain, Shareholders should generally be able to subtract from the cash received a proportion of their base cost of their Existing Ordinary Shares. Any gain will be taxable at applicable capital gains tax rates, and Shareholders may be able to take advantage of their annual exempt amount (£12,300 for 2022/23). The Share Consolidation should not have any material UK tax consequences.

An illustrative worked example will be made available on the Company’s website shortly after the implementation of the B Share Scheme and Share Consolidation.

More detail is contained in Part IV of the Circular and if you are in any doubt about the potential tax consequences of the B Share Scheme or the Share Consolidation for you, you should consult your own independent professional tax advisers.

 

This could depend on your precise circumstances, but in general the answer is “no”. UK individual Shareholders are likely to pay more tax on receipt of a special dividend than they would pay on receipt of proceeds under the B Share Scheme.

 

The Company has prepared a separate employee communications package that describes the tax treatment of the B Share Scheme in selected jurisdictions, depending on how employees hold their shares. Aviva employees should refer to the relevant page on Aviva World.

 

Sterling proceeds will be converted into US dollars by the Depositary, having regard to the prevailing exchange rate at the time of conversion (net of applicable fees, taxes and expenses), which is expected to be on Monday 6 June 2022.

 

It is expected that relevant Shareholders who hold their Ordinary Shares in certificated form or in the Aviva Share Account will receive their payments in respect of their B Shares including proceeds of fractional entitlements to their nominated bank, building society or financial institution account on the payment date, which is currently expected to be on or before Tuesday 31 May 2022 in respect of Ordinary Shares and promptly after Monday 6 June 2022 in respect of ADSs.

If Shareholders hold their Existing Ordinary Shares in CREST or ADSs in DTC, their CREST or DTC accounts are also expected to be credited by the payment date. All payments will be made in pounds sterling, save for ADS Holders who will receive their proceeds in US dollars following a conversion from pounds sterling by the Depositary, having regard to the prevailing exchange rate at the time of conversion (net of applicable fees, taxes, and expenses), which is expected to be on Monday 6 June 2022.

Fractional entitlements arising from the Share Consolidation will be aggregated and sold in the market on behalf of such Shareholders. Net proceeds of the sale (after deduction of all expenses and commissions incurred) are expected to be distributed pro rata to entitled Ordinary Shareholders by Tuesday 31 May 2022. The value of any one Shareholder's fractional entitlement will not exceed the value of one New Ordinary Share.

Shareholders can register a bank mandate instruction online by visiting www.computershare.com/AvivaInvestorCentre or calling the Aviva Shareholder Helpline on 0371 495 0105 or +44 117 378 8361 if calling from outside the UK. Where Computershare have not received an instruction at the time of a payment, the payment will be held by Computershare until the Shareholder has completed a valid instruction. No interest is payable on any payment held for Shareholders in this way.

 

Ordinary Shareholders will receive payments in respect of the proceeds from the B Share Scheme by way of electronic payments, or if you hold your Ordinary Shares in CREST, you will have your CREST account credited.

ADS Holders will receive payments in respect of the proceeds from the B Share Scheme by way of cheque, or if you hold your ADSs through DTC, you will have your DTC account credited.

Other than as set out above in respect of the ADS Holders, payments in respect of the proceeds from the B Share Scheme to Shareholders will not be effected by way of cheque. Where Computershare have not received a valid bank mandate instruction at the time of the payment, the payment will be held by Computershare until a valid instruction has been provided. No interest is payable on any payment held for you in this way.

Shareholders can register a bank mandate instruction online by visiting www.computershare.com/AvivaInvestorCentre or calling the Aviva Shareholder Helpline on 0371 495 0105 or +44 117 378 8361 if calling from outside the UK.

 

It is anticipated that no adjustment will be made to the number of Ordinary Shares over which participants have options or awards, or the relevant strike price of such options or awards (subject to the terms of the relevant plans).

 

If you are an Ordinary Shareholder outside of the United States and have questions on the B Share Scheme or Share Consolidation, please call the Shareholder Helpline on 0371 495 0105 (or +44 117 378 8361 if calling from outside the UK). The Shareholder Helpline is available from 8:30am to 5:30pm (UK time) Monday to Friday (except UK public holidays). Please note that calls to these numbers may be monitored or recorded. Calls to 0371 495 0105 from outside the UK are charged at applicable international rates. Different charges may apply to calls made from mobile telephones.

If you are an ADS Holder or Ordinary Shareholder in the United States and have questions in connection with the B Share Scheme or Share Consolidation, please call the information agent, Georgeson, at (866) 695-6075 (tollfree from the US) and (781) 575-2137 (from other countries), from 9am to 11pm (EST) Monday through Friday and from 12pm to 6pm (EST) on Saturdays.

For legal reasons, the Shareholder Helpline will be unable to give advice on the merits of the B Share Scheme or the Share Consolidation or to provide financial, tax or investment advice.

These FAQs do not take into account the investment objectives, financial situation or needs of any particular person. If you are in any doubt as to the action you should take, you are recommended to seek your own financial advice immediately from your stockbroker, bank manager, fund manager, solicitor, accountant or other appropriate independent financial adviser duly authorised under the Financial Services and Markets Act 2000 (FSMA) if you are resident in the United Kingdom or, if not, from another appropriately authorised independent financial adviser.

Download a PDF copy of these FAQs

Read our 2021 full year financial results announcement